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Abstract. 
 
The GTPase Rho is known to mediate the as-
sembly of integrin-containing focal adhesions and actin 
stress ﬁbers. Here, we investigate the role of Rho in reg-
ulating the distribution of the monocyte-binding recep-
tors E-selectin, ICAM-1, and VCAM-1 in human en-
dothelial cells. Inhibition of Rho activity with C3 
transferase or N19RhoA, a dominant negative RhoA 
mutant, reduced the adhesion of monocytes to acti-
vated endothelial cells and inhibited their spreading. 
Similar effects were observed after pretreatment of en-
dothelial cells with cytochalasin D. In contrast, domi-
nant negative Rac and Cdc42 proteins did not affect 
monocyte adhesion or spreading. C3 transferase and cy-
tochalasin D did not alter the expression levels of 
monocyte-binding receptors on endothelial cells, but 
did inhibit clustering of E-selectin, ICAM-1, and 
VCAM-1 on the cell surface induced by monocyte ad-
hesion or cross-linking antibodies. Similarly, N19RhoA 
inhibited receptor clustering. Monocyte adhesion and 
receptor cross-linking induced stress ﬁber assembly, 
and inhibitors of myosin light chain kinase prevented 
this response but did not affect receptor clustering. Fi-
nally, receptor clusters colocalized with ezrin/moesin/
radixin proteins. These results suggest that Rho is re-
quired in endothelial cells for the assembly of stable ad-
hesions with monocytes via the clustering of monocyte-
binding receptors and their association with the actin 
cytoskeleton, independent of stress ﬁber formation.
Key words: Rho • actin cytoskeleton • intercellular 
adhesion molecule-1 • E-selectin • monocyte adhesion
 
T
 
HE
 
 adhesion of monocytes to the vascular endo-
thelial lining and their subsequent diapedesis con-
 
stitutes one of the earliest changes detectable in
 
inflammation, immune responses, and atherosclerosis (Lus-
cinskas et al., 1996; O’Brien et al., 1996; Raines and Ross,
1996; McEvoy et al., 1997). Monocyte adhesion to endo-
thelial cells can be significantly upregulated by activating
the endothelium with inflammatory cytokines such as tu-
mor necrosis factor 
 
a
 
 (TNF-
 
a
 
),
 
1
 
 interleukin 1 (IL-1), and
IL-4 (Raines and Ross, 1996). Activated endothelial cells
express several monocyte-binding proteins including inter-
cellular adhesion molecule-1 (ICAM-1), ICAM-2, and
vascular cell adhesion molecule-1 (VCAM-1) of the im-
munoglobulin superfamily of adhesion molecules as well
as members of the selectin family of adhesion molecules,
E- and P-selectins (Bevilacqua and Nelson, 1993; Yoshida
et al., 1996). E-Selectin mediates the initial steps of mono-
cyte adhesion to endothelial cells, a process described as
leukocyte rolling (Hogg and Landis, 1993; Rice et al.,
1996). It is absent in unstimulated endothelial cells and is
rapidly expressed de novo in response to inflammatory cy-
tokines reaching a peak concentration after 
 
z
 
4 h of stimu-
lation (Bevilacqua et al., 1987; Bevilacqua and Nelson,
1993; Rice et al., 1996). ICAM-1 and VCAM-1 are re-
quired for stable adhesion, subsequent spreading, and dia-
pedesis of leukocytes through endothelium (Bevilacqua
and Nelson, 1993; Luscinskas et al., 1996). Although the
expression kinetics of these three molecules have been
studied extensively, the signaling mechanisms leading to
the formation of stable adhesions between endothelial
cells and leukocytes are still poorly understood.
The interactions between intracellular cytoskeletal com-
ponents and cell surface adhesion molecules have been
studied extensively because of their potential impact on
cell-cell and cell-substratum adhesion as well as receptor
internalization (Pavalko and Otey, 1994). The best charac-
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terized model for the association of integral membrane
proteins with the actin cytoskeleton is the focal adhesion,
found in places of integrin-mediated cell attachment to the
extracellular matrix (Burridge and Chrzanowska-Wod-
nicka, 1996; Hemler, 1998). Two of the leukocyte-binding
receptors on endothelial cells, E-selectin and ICAM-1,
have also been reported to associate with components of
the actin cytoskeleton (Carpen et al., 1992; Yoshida et al.,
1996). Clustering of E-selectin after leukocyte binding was
observed on IL-1–activated human umbilical vein endo-
thelial cells (HUVECs), and the cytoplasmic domain of
E-selectin was found to interact with a number of actin-
associated proteins, including 
 
a
 
-actinin, vinculin, filamin,
paxillin, and focal adhesion kinase (Yoshida et al., 1996).
The association of E-selectin with the cytoskeleton in-
creased the mechanical resistance of clustered E-selectin
to shear stress. Based on these observations, it was postu-
lated that the transmembrane anchoring of a cluster of
E-selectin molecules could serve as a physical nidus for coun-
teraction during the spreading and migration of leukocytes
to intercellular junctions that follows their stable arrest. In
addition, the intracellular signals transmitted to the cy-
toskeleton during E-selectin clustering could influence the
function of other endothelial adhesion molecules such as
ICAM-1 and VCAM-1 (Yoshida et al., 1996). Interest-
ingly, ICAM-1 can associate via its cytoplasmic domain
with 
 
a
 
-actinin, an actin-binding cytoskeletal protein (Car-
pen et al., 1992). Similar associations were also observed
with the adhesion proteins, ICAM-2, L-selectin, and 
 
b
 
1
and 
 
b
 
2 integrins (Heiska et al., 1996, 1998). The functional
implications of this binding have not been fully elucidated
but it may be that a cytoskeletal anchorage which immobi-
lizes ICAM-1 on endothelial cells could provide a firm ad-
hesive substratum for migrating leukocytes (Carpen et al.,
1992).
The three small GTP-binding proteins, Cdc42, Rac, and
Rho, are key mediators of actin cytoskeletal remodeling
induced by extracellular signals and also regulate the for-
mation of cell-cell and cell-substratum adhesions (Ridley,
1996; van Aelst and D’Souza-Schory, 1997). In particu-
lar, Rho is responsible for the formation and maintenance
of integrin-containing focal adhesions (Ridley and Hall,
1992), whereas Rac and Cdc42 mediate the assembly of
smaller adhesive complexes associated with lamellipodia
and filopodia (Nobes and Hall, 1995). The observation
that E-selectin and ICAM-1 associate with components of
the actin cytoskeleton suggested that Rho family proteins
could be involved in regulating adhesion mediated by
these receptors. Therefore, we have investigated the roles
of these proteins in regulating monocyte binding to TNF-
 
a
 
–activated human endothelial cells and clustering of
the monocyte-binding receptors, E-selectin, ICAM-1, and
VCAM-1. We have found that Rho but not Rac or Cdc42
is required for the initiation and maintenance of monocyte
adhesion to endothelial cells. In addition, Rho regulates
receptor clustering, most likely by mediating linkage of the
actin cytoskeleton to the membrane receptors. Clustering
of membrane receptors is independent of the activity of
the myosin light chain kinase (MLCK) and stress fibers,
and is therefore clearly different from the clustering of
integrins in focal contacts (Chrzanowska-Wodnicka and
Burridge, 1996).
 
Materials and Methods
 
Materials
 
Reagents were obtained from the following sources: medium 199 modified
Earle’s salt solution (Gibco Life Technologies); Clonetics EGM-2 me-
dium (TCS Biologicals Ltd.); Nutridoma NS (Boehringer Mannheim
Ltd.); human fibronectin, heparin, endothelial cell growth supplement,
bromodeoxyuridine (BrdU), cytochalasin D, 2,3-butanedione 2-mono-
xime, TRITC-phalloidin, 2,2
 
9
 
-azino-bis(3-ethylbenz-thiazoline-6-sulphonic
acid), and mouse monoclonal anti–human HLA class I antigen antibody
(Sigma Chemical Co.); TNF-
 
a
 
 (Insight Biotechnology); mouse mono-
clonal anti-CD45 and anti-CD14 antibodies (Leucogate; Becton Dickin-
son); mouse monoclonal anti-CD58 antibody and FITC-labeled goat
anti–rabbit IgG (Southern Biotechnology Associates); mouse monoclonal
anti-CD14 (SH-M1) antibody (Autogen Bioclear UK Ltd.); tetramethyl-
rhodamine dextran with a molecular weight of 10,000 (Molecular Probes);
mouse monoclonal anti–E/P-selectin (clone BBIG-E6), mouse mono-
clonal anti–ICAM-1 (function blocking, clone BBIG-I1), mouse mono-
clonal anti–VCAM-1 (function blocking, clone BBIG V1), mouse mono-
clonal anti–human E-selectin (function blocking, clone BBIG-E4), mouse
monoclonal anti–human P-selectin (function blocking, clone 9E1), goat
anti–human VCAM-1 polyclonal antibody, and goat polyclonal anti–
ICAM-1 antibody (R&D Systems); mouse monoclonal anti-myc (9E10)
antibody (Santa Cruz Biotechnology); FITC- and TRITC-labeled goat
anti–mouse and donkey anti–goat antibodies (Jackson ImmunoResearch
Laboratories); ML-7 (Calbiochem); Limulus Amoebocyte Lysate test
(Biowhittaker Inc.); protein assay kit (Bio-Rad); enhanced chemilumines-
cence kit (Amersham International plc); and polystyrene plates (Costar
Corp.). Rabbit polyclonal antiezrin, antimoesin, and antiradixin antibod-
ies were generously provided by Paul Mangeat (Montpellier, France);
pcDNA3 N19RhoA (myc epitope–tagged) was a kind gift from Alan Hall
(London, UK).
 
Cell Culture
 
HUVECs were a kind gift from Ruggero Pardi (Milano, Italy). The cells
were cultured in TC Nunclon flasks coated with 10 
 
m
 
g/ml human fibronec-
tin in medium 199 modified Earle’s salt solution containing 1.25 g/liter
NaHCO
 
3
 
 and Glutamax and supplemented with 20% FCS, 100 
 
m
 
g/ml en-
dothelial cell growth supplement, 1% Nutridoma NS, and 100 
 
m
 
g/ml hep-
arin. Cells were cultured at 37
 
8
 
C in humidified air containing 5% CO
 
2
 
. For
experiments cells were used between 3 and 7 passages.
MMVE-tsLT cells (kindly provided by Catherine Clarke, London, UK)
were human mammary microvascular endothelial cells expressing a tem-
perature-sensitive SV-40 large T antigen to extend their life span in cul-
ture. MMVE-tsLT cells were cultured in EGM-2 medium and used for ex-
periments up to 15 passages.
For microinjection experiments cells were grown on glass coverslips
coated with 10 
 
m
 
g/ml human fibronectin until confluent. Glass coverslips
were marked with a cross using a diamond pen to facilitate the localization
of microinjected cells. To obtain quiescent cells, the culture medium was
replaced by medium containing 10% FCS but no heparin or other growth
factors. Cells were incubated in this medium for 72 h and tested for DNA
synthesis by incubation with 10 
 
m
 
M BrdU for 24 h. The cells that had
incorporated BrdU were visualized as described previously (Wójciak-
Stothard et al., 1998). Over 97% of cells were quiescent and did not incor-
porate BrdU.
 
Isolation of Peripheral Blood Monocytes
 
Single donor platetephoresis residues were purchased from the North
London Blood Transfusion Service. Mononuclear cells were isolated by
Ficoll-Hypaque centrifugation (specific density, 1.077 g/ml) preceding
monocyte separation in a Beckman JE6 elutriator. Monocyte purity was
assessed by flow cytometry using directly conjugated anti-CD45 and anti-
CD14 antibodies and was routinely 
 
.
 
85%. All media and sera were rou-
tinely tested for endotoxin using the Limulus Amoebocyte Lysate test and
rejected if the endotoxin concentration exceeded 0.1 U/ml.
 
Measurement of Monocyte Adhesion and Spreading
 
To activate endothelial cells, TNF-
 
a
 
 was added at 100 ng/ml for 4 or 24 h.
Cell viability was tested after treatment with TNF-
 
a
 
 by a trypan blue ex-
clusion test. After 4 h endothelial cells were washed four times in culture 
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medium to remove TNF-
 
a
 
 and then purified human monocytes were
added at 5 
 
3
 
 10
 
5 
 
cells/ml and incubated for a further 2 h before fixation.
The monocyte/endothelial cell ratio in cocultures was 3.2 
 
6
 
 0.2.
Where indicated, cytochalasin D at 0.05 
 
m
 
g/ml was added to cell cul-
tures 3 h after addition of TNF-
 
a
 
 and incubated for 1 h. C3 transferase
was added to culture medium at 15 
 
m
 
g/ml 1 h after the addition of TNF-
 
a
 
and incubated together with TNF-
 
a
 
 for a further 3 h. To determine the
contribution of each monocyte-binding receptor to monocyte adhesion,
endothelial cells were incubated for 1 h with function-blocking antibodies
against E-selectin, P-selectin, ICAM-1, and VCAM-1 at 10 
 
m
 
g/ml before
the addition of monocytes.
The number of adherent monocytes and monocyte spread area was de-
termined using a confocal laser scanning microscope (MRC500; Bio-Rad).
To determine changes in the spread area of monocytes, images of the
basal aspect of the cells were collected and the area was measured using
the software integrated to the MRC500 (SOM, version 6.42 a) against a
Geller MRS-2 magnification reference standard 131 R3 (Agar Scientific
Ltd.). To estimate the extent of monocyte adhesion, the number of mono-
cytes bound per endothelial cell was calculated. Cell cultures were stained
for F-actin with TRITC-phalloidin and incubated with mouse monoclonal
anti-CD14 (SH-M1) antibody diluted 1:100 and FITC-labeled anti–mouse
IgG diluted 1:100 in order to facilitate identification of the adherent
monocytes. In each experiment 
 
.
 
500 endothelial cells were scored to cal-
culate monocyte adhesion, and experiments were performed in triplicate.
In some experiments endothelial cells were stained for E- and P-selectin,
ICAM-1, and VCAM-1 as described below.
 
Introduction of Recombinant Proteins into
Endothelial Cells
 
The recombinant proteins, V14RhoA, N17Rac1, N17Cdc42, and C3 trans-
ferase, were expressed in 
 
Escherichia coli
 
 from the pGEX-2T vector as
glutathione S-transferase fusion proteins and purified as described previ-
ously (Ridley et al., 1992). Protein concentrations were estimated using a
protein assay kit (Bio-Rad).
Proteins were microinjected into the cytoplasm of quiescent HUVECs
3.5 h after stimulation with TNF-
 
a
 
. After a 15-min incubation, the cells
were washed four times in culture medium and monocytes were added to
endothelial cell cultures. To identify injected cells, tetramethylrhodamine
dextran (molecular weight of 10,000) at 5 mg/ml was microinjected to-
gether with recombinant proteins. C3 transferase was microinjected at a
concentration of 4 
 
m
 
g/ml, V14RhoA was microinjected at 
 
z
 
100 
 
m
 
g/ml,
N17Rac1 at 7 mg/ml, and N17Cdc42 at 2 mg/ml. In experiments involving
receptor clustering C3 transferase was added to the culture medium at 15
 
m
 
g/ml, 1 h after the addition of TNF-
 
a
 
, and incubated together with TNF-
 
a
 
for a further 3 h.
To express N19RhoA, an expression vector containing myc epitope–
tagged N19RhoA cDNA (pcDNA3-N19RhoA) was microinjected at 0.05
mg/ml together with tetramethylrhodamine dextran into cell nuclei at the
same time as the addition of TNF-
 
a
 
, and cells were incubated for a further
3 h before adding antibodies to induce receptor clustering or for 4 h be-
fore assaying monocyte adhesion. Cells expressing N19RhoA were identi-
fied with the mouse monoclonal anti–myc epitope antibody 9E10 and
FITC-labeled anti–mouse antibody: 84% 
 
6
 
 10% of microinjected cells ex-
pressed detectable levels of N19RhoA.
 
Receptor Clustering, Immunofluorescence, and
Affinity Fluorescence
 
To induce receptor clustering, TNF-
 
a
 
 was added to endothelial cells and
then after 3 h mouse monoclonal antibodies to E-selectin, ICAM-1,
VCAM-1, HLA class I antigen, or CD58/LFA-3 were added to cells at a
final concentration of 10 
 
m
 
g/ml and incubated for 1 h at 37
 
8
 
C. The mouse
monoclonal anti–human E/P-selectin antibody used here recognizes both
E- and P-selectin on the surface of endothelial cells. Using mouse mono-
clonal antibodies that specifically recognized only E- or P-selectin, we
determined that TNF-
 
a
 
–activated HUVECs expressed predominantly
E-selectin and only very low levels of P-selectin, and therefore the results
obtained with the anti–E/P-selectin antibody relate to E-selectin.
After incubation with primary antibodies, TNF-
 
a
 
 and the primary anti-
bodies were removed from the cell medium and 10 
 
m
 
g/ml of FITC-labeled
goat anti–mouse antibody was added to the cells for 30 min. Cells were
then washed three times in PBS, fixed with 4% formaldehyde dissolved in
PBS for 10 min at room temperature, permeabilized for 6 min with 0.2%
Triton X-100, and then incubated with 1 
 
m
 
g/ml TRITC-phalloidin for 45
 
min to stain actin filaments, or for 1 h with rabbit polyclonal antiezrin, an-
timoesin, or antiradixin antibodies diluted 1:200, followed by 5 
 
m
 
g/ml
TRITC-labeled goat anti–rabbit antibody for 1 h. The specimens were
mounted in moviol. To examine the extent of spontaneous receptor clus-
tering upon the addition of the primary antibodies only, TNF-
 
a
 
–stimu-
lated HUVECs were incubated for 1 h with the primary antibodies as de-
scribed above, and then fixed. Fixed cells were then incubated with the
secondary antibody for 30 min, washed, permeabilized, and stained for ac-
tin filaments. For controls, nonstimulated HUVECs or HUVECs that
were stimulated with TNF-
 
a
 
 for 4 h were used. The cells were then fixed,
incubated with primary and secondary antibodies, and then permeabilized
and stained for actin as described above.
In experiments with MLCK inhibitors, ML-7 (40 
 
m
 
M) and 2,3-butane-
dione 2-monoxime (BDM) (5 mM) were added to cell cultures together
with the primary antibody, 3 h after stimulation with TNF-
 
a
 
. After a 1-h
incubation, the cells were washed as described before, and the inhibitors
were added again together with the secondary antibody and incubated for
30 min. The cells were then washed, fixed, and stained for actin filaments
as described above.
Confocal laser scanning microscopy was carried out with an LSM 310
or 510 (Zeiss) mounted over an infinity corrected Axioplan microscope
(Zeiss) fitted with a 
 
3
 
10 eyepiece, using either a 
 
3
 
40 NA 1.3 or a 
 
3
 
63 NA
1.4 oil immersion objective. Image files were collected as a matrix of 1024 
 
3
 
1024 pixels describing the average of 8 frames scanned at 0.062 Hz where
FITC and TRITC were excited at 488 nm and 543 nm and visualized with
a 540 
 
6
 
 25 and a 608 
 
6
 
 32 nm bandpass filters, respectively, where the lev-
els of interchannel cross-talk were insignificant.
 
Cell Surface Immunoassay
 
To measure the cell surface expression of E-selectin, ICAM-1, and
VCAM-1 we used an ELISA assay as described by Zund et al. (1996) with
some modifications. In brief, HUVECs were plated onto fibronectin-
coated 96-well polystyrene plates at a density of 2 
 
3
 
 10
 
4
 
 cells/well and
grown for 48 h. The cells were then incubated in starvation medium (10%
FCS) for 24 h. The cells were stimulated with TNF-
 
a
 
 for 4 or 24 h and,
where indicated, cytochalasin D at 0.05 
 
m
 
g/ml was added to cell cultures 3
or 23 h after addition of TNF-
 
a
 
 and incubated for 1 h. C3 transferase was
added to the culture medium at 15 
 
m
 
g/ml either 1 or 21 h after the addition
of TNF-
 
a
 
 and incubated together with TNF-
 
a
 
 for a further 3 h. In con-
trols, C3 transferase and cytochalasin D were added to nonstimulated
cells. Cells were washed three times in PBS and then fixed in 1%
paraformaldehyde at 4
 
8
 
C for 15 min. The cells were washed three times in
PBS and then incubated overnight with 1% BSA solution in PBS at 4
 
8
 
C.
All wells were then washed three times in PBS and incubated for 2 h at
room temperature with 200 
 
m
 
l/well of 0.5% BSA solution containing 5
 
m
 
g/ml of mouse monoclonal anti–human E/P-selectin antibody, mouse
monoclonal anti–human ICAM-1 antibody or goat anti–human VCAM-1
antibody. Subsequently, cells were washed three times in PBS and incu-
bated with 200 
 
m
 
l of HRP-conjugated rabbit anti–mouse IgG or donkey
HRP-conjugated anti–goat IgG solution at 1:1,000 in 0.5% BSA for 1 h at
room temperature. After washing, plates were developed by addition
of peroxidase substrate, 2,2
 
9
 
-azino-bis(3-ethylbenz-thiazoline-6-sulphonic
acid) and OD at 650 nm was determined on a microtiter plate spectropho-
tometer. Data are presented as mean 
 
6
 
 SD (background subtracted).
 
Western Blotting
 
HUVECs were grown to confluence in 40-mm plastic petri dishes pre-
coated with human fibronectin and starved for 24 h in 10% FCS as de-
scribed above. TNF-
 
a
 
 was added as indicated and incubated with cells for
4 or 24 h. Cytochalasin D and C3 transferase were added as described
above (cell surface immunoassay). Cells were washed, lysed, and debris
was removed by centrifugation at 14,000 rpm. The protein concentration
was measured using a Bio-Rad protein assay. Equal amounts of protein
were separated by SDS-PAGE on 7.5% polyacrylamide gels under nonre-
ducing conditions, and transferred to nitrocellulose membranes, which
then were blocked overnight with 5% nonfat dry milk powder in TBS
(20 mM Tris-HCl, pH 7.6, 137 mM NaCl) containing 0.05% Tween 20.
This was followed by incubation with anti–E/P-selectin, mouse mono-
clonal anti–ICAM-1, or goat anti–VCAM-1 antibodies diluted 1:500 in
TBS-Tween containing 1% dried milk powder for 2 h. Blots were then
washed three times in TBS-Tween and incubated for 1 h at room tempera-
ture with HRP-conjugated sheep anti–mouse antibodies diluted 1:2,000.
Membranes were developed using an enhanced chemiluminescence kit
(Amersham International). 
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Results
 
C3 Transferase and Cytochalasin D Inhibit Monocyte 
Adhesion and Spreading on Endothelial Cells
 
Human monocytes showed low levels of adhesion to un-
stimulated, quiescent HUVECs (Fig. 1 a). The few adher-
ent cells retained a regular, rounded morphology similar
to that observed in a suspension of freshly isolated mono-
cytes (Fig. 2 a). Monocyte adhesion increased sevenfold
after stimulation of endothelial cells with TNF-
 
a
 
 (Figs. 1 a
and 2 c).
To determine whether Rho in endothelial cells plays a
role in monocyte adhesion, we treated cells with C3 trans-
ferase, an exoenzyme produced by 
 
Clostridium botulinum
 
which inhibits Rho by ADP ribosylation (von Eichel-
Streiber et al., 1996). The TNF-
 
a
 
–induced increase in
monocyte adhesion was reduced by 55% in HUVECs in-
cubated with C3 transferase (Fig. 1 a). Monocyte adhesion
was also inhibited in TNF-
 
a
 
–stimulated HUVECs which
were microinjected with C3 transferase 30 min before the
addition of monocytes (Fig. 2 d). Under the conditions
used here, C3 transferase induced loss of stress fibers but
did not induce cell rounding (Fig. 2 d). To provide further
evidence for the involvement of Rho in monocyte adhe-
sion, HUVECs were microinjected with a plasmid encod-
ing N19RhoA, a dominant negative RhoA protein. In cells
expressing N19RhoA, monocyte adhesion was reduced by
75% compared with control-injected cells (Fig. 1 a).
As Rho is known to induce actin reorganization, we spe-
cifically investigated the involvement of the endothelial
cell actin cytoskeleton in monocyte adhesion by pretreat-
 
ing endothelial cells with cytochalasin D before addition
of monocytes. Cytochalasin D inhibits addition of actin
monomers to the barbed ends of actin filaments (Cooper,
1987), and as expected it induced a decrease in actin cables
in HUVECs (see Fig. 7 i). It was necessary to wash out cy-
tochalasin D from the medium before addition of mono-
cytes, to prevent it acting on the monocytes. Control ex-
periments showed that although the effects of cytochalasin
D on the actin cytoskeleton of HUVECs were reversible,
few actin cables reappeared during the 2-h incubation with
monocytes. By 4 h after cytochalasin D removal, however,
the actin cytoskeleton was essentially indistinguishable
from that of untreated cells (data not shown). Monocyte
adhesion was substantially inhibited in HUVECs pre-
treated with cytochalasin D (Fig. 1 a), indicating that the
actin cytoskeleton in endothelial cells is important for pro-
moting monocyte adhesion.
Monocytes attached to TNF-
 
a
 
–treated HUVECs showed
an approximately twofold increase in their spread area rel-
ative to monocytes on unstimulated endothelial cells (Fig.
1 c). Many monocytes become elongated and extended
lamellipodia, characteristic of a migratory phenotype (Fig.
2, c and e). The few monocytes that did attach to C3 trans-
ferase– or cytochalasin D–treated activated HUVECs did
not spread significantly (Fig. 1 c).
As with HUVECs, adhesion of monocytes to nonacti-
vated MMVE-tsLT cells was low and adherent monocytes
remained rounded and unspread (Fig. 1, b and d, and Fig.
2 b). The addition of TNF-
 
a
 
 to MMVE-tsLT cells in-
creased the number of adherent monocytes fivefold (Fig. 1
b). This effect was almost completely inhibited by the ad-
Figure 1. Rho but not Rac or Cdc42
are required for the adhesion and
spreading of monocytes on TNF-
a–activated endothelial cells. Where
indicated, endothelial cells were acti-
vated with TNF-a for 4 h. During this
incubation time, cells were treated
with C3 transferase (C3) for 3 h; cy-
tochalasin D (CD) for 1 h; microin-
jected with V14RhoA (Rho), N17Rac
(NRc), N17Cdc42 (NCd), or fluores-
cent dextran (DX) 3.5 h after TNF-a
addition; or microinjected with
pcDNA3-N19RhoA (N19) immedi-
ately after TNF-a addition. Mono-
cytes were then added to endothelial
cells for 2 h before fixation. a and b
show the number of attached mono-
cytes per endothelial cell in HUVEC
and MMVE-tsLT cultures, respec-
tively. c and d show the spread area of
monocytes adherent to HUVEC and
MMVE-tsLT cell cultures, respec-
tively. Each experiment was per-
formed in triplicate. All results are ex-
pressed as means 6 1 SD. The
unpaired Student’s t test was used to
compare differences between control
TNF-a–activated cells and cells treated
or microinjected with the indicated
substances. *P # 0.05; **P , 0.01. 
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dition of C3 transferase or cytochalasin D to endothelial
cells stimulated with TNF-
 
a
 
 (Fig. 1 b, see also Fig. 2, e and
f). Similar to HUVECs, the treatment of MMVE-tsLT
cells with C3 transferase or cytochalasin D inhibited
monocyte spreading on endothelial cells (Fig. 1 d).
As these results indicate that endothelial cell Rho is in-
volved in regulating monocyte adhesion, we investigated
whether the related proteins, Rac and Cdc42, also affect
this process. Microinjection of TNF-
 
a
 
–activated HUVECs
with dominant inhibitory Rac or Cdc42 protein, N17Rac1
or N17Cdc42, did not significantly change monocyte adhe-
sion or spreading (Figs. 1 a and 3 a). The N17Cdc42 and
N17Rac1 protein preparations were active as they were
able to inhibit the formation of stress fibers in TNF-
 
a
 
–acti-
vated HUVECs (see Wójciak-Stothard et al., 1998). We
conclude that Rho but not Rac or Cdc42 in endothelial cells
is involved in the formation and maintenance of intercellu-
lar adhesions between monocytes and endothelial cells.
 
V14RhoA Increases the Attachment of Monocytes to 
Endothelial Cells
 
As our results indicate that Rho is required in endothelial
cells for monocyte adhesion, we investigated the effects of
introducing activated Rho into endothelial cells. Microin-
jection of constitutively activated Rho protein, V14RhoA,
into quiescent, unstimulated cells did not enhance mono-
cyte adhesion (Fig. 1 a), whereas in TNF-
 
a
 
–treated HU-
VECs V14RhoA induced a small but significant increase
in monocyte adhesion (Fig. 1 a). Monocytes tended to
form clusters around the cells microinjected with V14-
RhoA (Fig. 3 c). This was not a nonspecific consequence
of microinjection because injection of fluorescent dextran
into TNF-
 
a
 
–activated endothelial cells did not have a sig-
nificant effect on monocyte adhesion (Fig. 1 a). These re-
sults provide further evidence for a role of Rho in promot-
ing monocyte adhesion.
Figure 2. Inhibition of monocyte at-
tachment and spreading on activated
endothelial cells microinjected with C3
transferase. Monocytes were incubated
for 2 h with control, unstimulated HU-
VECs (a), control, unstimulated
MMVE-tsLT cells (b), TNF-a–acti-
vated HUVECs (c), and C3 trans-
ferase-microinjected HUVECs acti-
vated with TNF-a for 4 h (d) (the
arrow points to the area of microin-
jected cells); TNF-a–activated MMVE-
tsLT cells (e); and C3 transferase–micro-
injected TNF-a–activated MMVE-tsLT
cells (f). Cells were then fixed and
stained with FITC-phalloidin to show
F-actin. The image in g corresponds to
f and shows TRITC-dextran, which
was coinjected with C3 transferase to
visualize the injected cells. Bar, 10 mm. 
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E-Selectin, ICAM-1, and VCAM-1 Are
Major Monocyte-binding Receptors in
TNF-
 
a
 
–activated HUVECs
To investigate how Rho regulates monocyte adhesion and
spreading, we first determined the involvement of differ-
ent receptors for monocytes in mediating monocyte adhe-
sion to TNF-a–activated monocytes. We focused specifi-
cally on E-selectin, ICAM-1, and VCAM-1, as these are
the three major monocyte-binding receptors on HUVECs
known to be upregulated by TNF-a (Luscinskas et al.,
1996; May et al., 1996; Schleiffenbaum and Fehr, 1996;
Melrose et al., 1998). As expected from previous studies
(Beekhuizen and van Furth, 1993; Luscinskas et al., 1996;
May et al., 1996), quiescent endothelial cells showed very
low surface expression levels of E-selectin, ICAM-1, and
VCAM-1 (Fig. 4, a, e, and g). TNF-a increased the surface
expression of these three proteins by 4 h after stimulation
(Fig. 4, b, f, and h). The levels of spontaneous receptor
clustering were relatively low. ICAM-1 in TNF-a–treated
cells tended to accumulate in the region of intercellular
junctions (Fig. 4 f). The first changes in the expression of
E-selectin were detectable by immunofluorescence 1 h af-
ter cell activation (data not shown). An increase in intra-
cellular levels of E-selectin indicating de novo synthesis of
the protein was also observed 2 h after stimulation with
TNF-a (Fig. 4 d) (Weller et al., 1992).
Addition of function-blocking antibodies against E-selec-
tin, ICAM-1, and VCAM-1 showed that each of these re-
ceptors contributed to monocyte adhesion to TNF-a–acti-
vated HUVECs. Antibodies against E-selectin, ICAM-1,
and VCAM-1 inhibited monocyte adhesion by 17% 6 5%,
34% 6 9%, and 24% 6 8%, respectively. Anti–P-selectin
antibodies did not significantly reduce monocyte adhesion,
reflecting the low level of P-selectin expression in HU-
VECs (see Materials and Methods). Inclusion of all four
antibodies against E-selectin, P-selectin, ICAM-1, and
VCAM-1 inhibited monocyte adhesion by 61% 6 12%.
Similar results with adhesion-blocking antibodies carried
out in stationary (nonflow) conditions have been reported
previously (Luscinskas et al., 1996). These results indicate
that E-selectin, ICAM-1, and VCAM-1 are major mono-
cyte-binding receptors on TNF-a–activated HUVECs, al-
though this does not rule out a contribution of other re-
ceptors such as ICAM-2, CD31/PECAM-1, or avb3 in
monocyte–endothelial cell interactions (Schleiffenbaum
and Fehr, 1996; Brown, 1997).
C3 Transferase and Cytochalasin D Do Not Alter the 
Expression Levels of E-Selectin, ICAM-1, or VCAM-1
One possible explanation for the decreased binding of
monocytes to endothelial cells treated with C3 transferase
or cytochalasin D is that there are lower levels of mono-
cyte-binding receptors on the cell surface. To investigate
this possibility, a cell surface immunoassay was performed
on fixed monolayers of TNF-a–activated HUVECs (Fig.
5). Endothelial cells were stimulated with TNF-a for 4 or
24 h either with or without addition of C3 transferase for
the last 3 h or cytochalasin D for 1 h before fixation. Anal-
ysis of receptor levels by ELISA showed that neither C3
transferase nor cytochalasin D induced any significant
changes in the surface expression of E-selectin (Fig. 5 a),
ICAM-1 (Fig. 5 b), or VCAM-1 (Fig. 5 c). Western blot
Figure 3. Effects of N17Cdc42 and
V14RhoA on monocyte adhesion
to HUVECs. TNF-a–activated HU-
VECs were microinjected with
N17Cdc42 (a and b) or V14RhoA (c
and d) 30 min before addition of
monocytes for 2 h. Cells were then
fixed and stained with FITC-phalloidin
to show actin filaments (a and c); mi-
croinjected cells were visualized by
coinjection of TRITC-dextran (b and
d). Bar, 10 mm.Wjciak-Stothard et al. Rho Regulates Monocyte Binding to Endothelial Cells 1299
analysis of TNF-a–treated HUVECs showed that the
overall level of expression of E-selectin, ICAM-1, or
VCAM-1 in HUVECs was also not altered by treatment
with C3 transferase or cytochalasin D (data not shown).
Monocyte Adhesion Induces Rho-mediated Changes in 
the Distribution of E-Selectin, ICAM-1, and VCAM-1 
in HUVECs
Clustering of E-selectin in endothelial cells has been pos-
tulated to be an initial step leading to the linkage of recep-
tors to the cytoskeleton and stabilization of cell adhesion
(Yoshida et al., 1996). We observed an accumulation of
E-selectin on the surface of activated HUVECs around
the margin of adhering monocytes (Fig. 6 b, arrow) and an
overall increase in receptor clustering often unrelated to
the position of a monocyte (Fig. 6 b). The position of ad-
hering monocytes was determined by F-actin staining (Fig.
6 a). ICAM-1 also accumulated along the margin of at-
tached monocytes outlining fine protrusions formed by the
monocyte membrane (Fig. 6, c and d).
In contrast, VCAM-1 did not significantly change its dis-
tribution upon the adhesion of monocytes. Clustering of
receptors was seen only in a few places where monocytes
were attached and the positions of clusters were unrelated
to monocyte margins (Fig. 6, e and f). In endothelial cells
Figure 4. Expression of the monocyte-binding receptors E-selec-
tin, ICAM-1, and VCAM-1 is increased in TNF-a–activated HU-
VECs. Surface expression in unstimulated, quiescent HUVECs is
shown for E-selectin (a), ICAM-1 (e), and VCAM-1 (g). Increase
in surface expression after treatment for 4 h with TNF-a is shown
for E-selectin (b), ICAM-1 (f), and VCAM-1 (h). In c (no TNF-a)
and d (TNF-a for 2 h), cells were permeabilized after fixation to
reveal intracellular E-selectin. Bar, 10 mm.
Figure 5. C3 transferase and cytochalasin D do not alter surface
expression levels of E-selectin, ICAM-1, and VCAM-1 on HU-
VECs. Quiescent HUVECs were stimulated with TNF-a for 4 or
24 h and treated as indicated with C3 transferase (C3) or cytocha-
lasin D (CD) for the last 3 or 1 h, respectively, of this incubation
period. Cells were then fixed and the surface expression levels of
E-selectin (a), ICAM-1 (b), and VCAM-1 (c) were determined
by ELISA assay. All results are expressed as means 6 1 SD, and
the unpaired Student’s t test was used to compare differences be-
tween groups (n 5 4). The differences in surface expression of re-
ceptors in activated HUVECs compared with C3- or CD-treated
activated HUVECs were statistically insignificant (P . 0.1).The Journal of Cell Biology, Volume 145, 1999 1300
that were treated with C3 transferase, E-selectin accumu-
lation (Fig. 6, g and h) and clustering of ICAM-1 (Fig. 6, i
and j) at the margin of the few adhering monocytes were
much reduced. This lack of clustering could be a conse-
quence of weaker monocyte adhesion which is unable to
signal sufficiently to induce clustering, or represent a re-
quirement for Rho in the process of clustering, which in
turn is required for stable adhesion.
C3 Transferase and Cytochalasin D Inhibit Clustering 
of Monocyte-binding Receptors on HUVECs
We have shown that although C3 transferase and cyto-
chalasin D did not change the expression levels of mono-
cyte-binding receptors, they inhibited the binding and
spreading of monocytes on endothelial cells and inhibited
receptor clustering around the adherent monocytes. To
investigate further the role of Rho in regulating receptor
clustering we mimicked clustering induced by adhering
monocytes by incubating HUVECs with primary antibod-
ies against E-selectin, ICAM-1, and VCAM-1 and then
cross-linking them with fluorescently labeled secondary
antibody. This technique of clustering membrane recep-
tors with specific antibodies has been described previously
(Kornberg et al., 1991, 1992; Jewell et al., 1995; Yoshida
et al., 1996).
Treatment of TNF-a–activated HUVECs with antibod-
ies against E/P-selectin induced spontaneous clustering of
E-selectin (Fig. 7 a) which was enhanced by the addition of
secondary, cross-linking antibodies (Fig. 7 b). Clustering
of E-selectin with primary antibodies alone or with pri-
mary antibodies followed by secondary antibodies was sig-
nificantly reduced by the treatment of endothelial cells
with C3 transferase (Fig. 7, d and f) or cytochalasin D (Fig.
7, h and j). Both C3 transferase and cytochalasin D also in-
hibited stress fiber formation, but under the conditions
used did not induce cell rounding or detachment (Fig. 7, c,
g, and i).
ICAM-1 in TNF-a–treated HUVECs incubated with
only the primary antibody was localized mainly in the
intercellular junctions (Fig. 8 a). Addition of second-
ary (cross-linking) antibodies caused a disappearance of
ICAM-1 from the junctions and clustering of the receptors
on the cell surface (Fig. 8 b). This was not a consequence
of loss of intercellular junctions, as VE-cadherin localiza-
tion to junctions was not altered by ICAM-1 cross-linking
(data not shown). C3 transferase significantly inhibited an-
tibody-induced clustering of ICAM-1 on the cell surface
Figure 6. Adhesion of monocytes in-
duces Rho-dependent clustering of
E-selectin and ICAM-1 on HUVECs.
HUVECs were treated with TNF-a for
4 h, then TNF-a was washed out and
monocytes were added for 2 h. Cells
were stained in a, c, e, g, and i for actin
filaments to show the position of at-
tached monocytes on the surface of en-
dothelial cells and correspond to im-
ages b, d, f, h, and j, respectively.
Clustering of E-selectin at the margin
of an adhering monocyte is shown in
b, ICAM-1 in d, and clustering of
VCAM-1, unrelated to the position of
monocytes, is shown in f (arrow);
E-selectin (h) and ICAM-1 (j) cluster-
ing at the margin of monocytes is in-
hibited in HUVECs preincubated with
C3 transferase for 3 h before addition
of monocytes. Bar, 5 mm.Wjciak-Stothard et al. Rho Regulates Monocyte Binding to Endothelial Cells 1301
(Fig. 8 d). It also reduced the localization of ICAM-1 to
cell junctions, although again VE-cadherin localization
was not altered (data not shown). Expression of dominant
negative N19RhoA protein in endothelial cells also inhib-
ited antibody-induced ICAM-1 clustering (Fig. 8, e and f)
and E-selectin clustering (data not shown), providing fur-
ther evidence that Rho plays a specific role in regulating
receptor clustering.
Some clusters of VCAM-1 were present on the surface
of TNF-a–activated HUVECs treated with anti–VCAM-1
antibody (Fig. 8 g), but addition of secondary antibodies
caused a marked increase in VCAM-1 clustering (Fig. 8 h).
Pretreatment of the cells with C3 transferase (Fig. 8 j) or
expression of N19RhoA (data not shown) inhibited clus-
tering of VCAM-1 induced by the secondary antibodies.
Clustering induced by the primary anti–VCAM-1 or anti–
ICAM-1 antibodies alone was also inhibited by C3 trans-
ferase, and ICAM-1 and VCAM-1 clustering was simi-
larly inhibited by cytochalasin D treatment (data not
shown).
Figure 7. E-selectin clustering is inhib-
ited by C3 transferase and cytochalasin
D in HUVECs. HUVECs were acti-
vated with TNF-a for 4 h then incu-
bated with mouse anti–E-selectin anti-
body for 1 h. In a, d, and h, they were
then fixed and stained with FITC-
labeled goat anti–mouse IgG; in b, f,
and j, they were incubated with FITC-
labeled goat anti–mouse IgG for 30
min before fixation. In d and f, cells
were incubated for 3 h with C3 trans-
ferase before addition of antibodies; in
h and j cells were incubated with cy-
tochalasin D for 1 h before antibody
addition. F-Actin distribution is shown
in c, e, g, and i; these images corre-
spond to d, f, h, and j, respectively.
Bar, 10 mm.The Journal of Cell Biology, Volume 145, 1999 1302
Clustering of E-Selectin, ICAM-1, and VCAM-1 Is Not 
Dependent upon the Activity of MLCK and Does Not 
Require the Presence of Stress Fibers
Cross-linking of E-selectin, ICAM-1, and VCAM-1 with
antibodies was accompanied by increased stress fiber ac-
cumulation and appearance of intercellular gaps, indica-
tive of increased contractility (Fig. 9 b and data not
shown). Adhesion of monocytes to TNF-a–activated en-
dothelial cells also induced stress fiber formation (com-
pare Fig. 2 c with Fig. 9 a), consistent with previous ob-
servations (Lorenzon et al., 1998). Antibody-induced
clustering of HLA class I antigen or CD58/LFA-3, a recep-
tor of the Ig superfamily (Springer, 1990), did not induce
stress fiber formation, showing that this is not a general re-
sponse to receptor clustering but is restricted to specific
receptors (data not shown). C3 transferase inhibited the
formation of stress fibers induced by the use of cross-link-
ing antibodies (Fig. 7, c and e, and Fig. 8, c and i) or by
monocyte adhesion (Fig. 2 d), indicating that Rho is re-
quired for this response. To investigate whether the mech-
anism of receptor clustering on HUVECs is linked to
stress fiber formation and/or is dependent on the activity
of MLCK, as was suggested for the Rho-mediated assem-
bly of integrins into focal contacts (Chrzanowska-Wod-
nicka and Burridge, 1996), we used two MLCK inhibitors
ML-7 and BDM. ML-7 is a potent and selective inhibitor
of both Ca21-dependent and -independent MLCKs (Sai-
toh et al., 1986). BDM acts as an inhibitor of muscle myo-
Figure 8. Rho is required for ICAM-1 and
VCAM-1 clustering in HUVECs. In a–f, TNF-
a–activated HUVECs were incubated for 1 h
with mouse anti–ICAM-1 antibody. In a, cells
were fixed and stained with FITC-labeled goat
anti–mouse IgG; in b–f, they were incubated for
30 min with secondary, FITC-labeled goat anti–
mouse IgG before fixation. In d, E-selectin dis-
tribution is shown in cells that were incubated
with C3 transferase for 3 h before addition of an-
tibodies; c corresponds to d and shows F-actin;
in e, cells were microinjected with pcDNA3-
N19RhoA plasmid 3 h after TNF-a addition,
then incubated for a further 3 h before antibody
addition; f shows control cells for e incubated
with TNF-a for 6 h before antibody addition. In
g–j, TNF-a–activated HUVECs were incubated
with goat anti–VCAM-1 antibody for 1 h. In g,
they were then fixed and stained with FITC-
labeled anti–goat IgG; in h–j, they were incu-
bated for 30 min with FITC-labeled anti–goat
IgG before fixation. In j, VCAM-1 distribution is
shown in cells incubated with C3 transferase for
3 h before antibody addition; i corresponds to j
and shows F-actin distribution. Bar, in a–d and
g–j, 10 mm; in e and f, 3 mm.Wjciak-Stothard et al. Rho Regulates Monocyte Binding to Endothelial Cells 1303
sin ATPase activity (Higuchi and Takemori, 1989). Both
inhibitors caused a loss of stress fibers in HUVECs, as pre-
viously reported (Wójciak-Stothard et al., 1998) (Fig. 9, c
and e), but did not inhibit the antibody-induced clustering
of E-selectin (Fig. 9 d), ICAM-1 (Fig. 9 f), or VCAM-1
(data not shown).
These results show that neither Rho-mediated stress fi-
ber formation nor myosin-dependent contractility is nec-
essary for receptor clustering, implying that Rho inde-
pendently induces the clustering of monocyte-binding
receptors and stress fiber formation. Therefore, we sought
to determine whether F-actin or associated proteins were
detectably linked with clusters of monocyte-binding recep-
tors. The localization of E-selectin (Fig. 10 b), ICAM-1,
and VCAM-1 (data not shown) after antibody-induced re-
ceptor clustering was not related to stress fibers in HU-
VECs (Fig. 10 a). Some large clusters of E-selectin (Fig. 10
a), ICAM-1, and VCAM-1 (data not shown) colocalized
with F-actin, and in these cases the F-actin often appeared
to form a ring around the cluster (Fig. 10 a, arrow). How-
ever, F-actin did not detectably colocalize with most clus-
ters of receptors, suggesting that if they are linked with the
actin cytoskeleton this does not require the presence of
large actin-containing structures.
Ezrin/radixin/moesin (ERM) proteins can provide a link
between some membrane receptors and the actin cytoskel-
eton, and in particular ICAM-1 has been reported to inter-
act with ezrin in vitro (Heiska et al., 1998). Antibody-
induced clusters of ICAM-1 (Fig. 10 d), VCAM-1 (Fig. 10
f), and E-selectin (data not shown) often colocalized with
moesin (Fig. 10, c and e), ezrin, and radixin (data not
shown). This was observed with both small and large clus-
ters of receptors (Fig. 10, arrows). This colocalization of
ERM proteins with monocyte-binding receptors was not
a nonspecific consequence of antibody-induced receptor
clustering, as antibody-induced clusters of HLA class I an-
tigen did not colocalize with moesin (Fig. 10, g and h),
ezrin, or radixin (data not shown). Similarly, clusters of
CD58/LFA-3 did not colocalize with ERM proteins (data
not shown).
Discussion
In vivo, leukocyte adhesion to endothelial cells is a prereq-
Figure 9. Inhibitors of MLCK have no
effect on receptor clustering in HU-
VECs. In all cases, quiescent HUVECs
were activated with TNF-a for 4 h.
Cells were then fixed (a); or treated
with primary, anti–E-selectin antibody
and secondary, cross-linking antibody
before fixation (b–f). In a and b,
F-actin localization is shown. The im-
ages in c and d show F-actin (c) and
E-selectin localization (d) in cells
treated with ML-7; e and f show
F-actin (e) and ICAM-1 (f) localiza-
tion in cells treated with BDM (f). Bar,
10 mm.The Journal of Cell Biology, Volume 145, 1999 1304
uisite for subsequent transmigration across the endothe-
lium into underlying tissues. In this paper we have demon-
strated that Rho in endothelial cells is required for the
adhesion and spreading of monocytes, and modulates the
clustering of the monocyte-binding receptors, E-selectin,
ICAM-1, and VCAM-1, induced by monocyte adhesion or
by cross-linking antibodies. This clustering is dependent
on the actin cytoskeleton, as it is prevented by cytochala-
sin D, an inhibitor of actin polymerization, which also in-
hibits monocyte adhesion. These results demonstrate that
responses in endothelial cells activated by receptor en-
gagement are crucial for stable monocyte adhesion, and
suggest that Rho may regulate the linkage between mono-
cyte-binding receptors and the actin cytoskeleton to allow
the formation of adhesion foci between monocytes and en-
dothelial cells.
Figure 10. Colocalization of clusters of
E-selectin, ICAM-1, and VCAM-1
with F-actin and ERM proteins. HU-
VECs were activated with TNF-a for
4 h, then receptors were cross-linked
with receptor-specific antibodies fol-
lowed by FITC-labeled secondary anti-
bodies (see Materials and Methods). In
a, F-actin distribution is shown in HU-
VECs treated with cross-linking anti-
bodies against E-selectin. The image in
b is the F-actin image in a (red) merged
with the corresponding image showing
E-selectin (green) localization. Large
clusters of E-selectin colocalize with
F-actin, as indicated by arrows in a.
Moesin distribution is shown in cells
treated with cross-linking antibodies
against ICAM-1 (c), VCAM-1 (e), or
HLA class I antigen (g). The merged
images in d, f, and h are the same
moesin images (red) merged with cor-
responding (green) images showing
ICAM-1 (d), VCAM-1 (f), and HLA
class I antigen (h) localization. Yellow
color in these merged images indicates
colocalization of moesin with the re-
spective receptors. Arrows indicate ex-
amples of colocalization of moesin
with receptors. Bar, a and b, 5 mm; in
c–h, 10 mm.Wjciak-Stothard et al. Rho Regulates Monocyte Binding to Endothelial Cells 1305
The precise links between leukocyte-binding receptors
and the actin cytoskeleton have not been identified, but
ICAM-1, ICAM-2, and E- and L-selectins have all been
reported to associate with actin-binding proteins (Carpen
et al., 1992; Yoshida et al., 1996; Brenner et al., 1997;
Heiska et al., 1998). Clustering of adhesion receptors has
been suggested to play a mechanical role in strengthening
cell-cell or cell-extracellular matrix adhesion. In fibro-
blasts, tension transmitted via extracellular matrix pro-
teins to integrins can strengthen their linkage to the cy-
toskeleton, and lead to further clustering of integrins
(Choquet et al., 1997). Similar responses may occur after
leukocyte binding to endothelial cells. E-Selectin clusters
and associates with the actin cytoskeleton during leuko-
cyte adhesion; this linkage increases the stress resistance
of the ligand-receptor binding and can be inhibited by cy-
tochalasin D (Yoshida et al., 1996). We have observed
clustering of both E-selectin and ICAM-1 at the margin of
adhering monocytes, and in addition found that F-actin
colocalized with large clusters of antibody cross-linked re-
ceptors, suggesting association of these clusters with the
actin cytoskeleton. Clusters of E-selectin, ICAM-1, and
VCAM-1 also colocalized with ERM proteins, which are
known to interact with F-actin (Heiska et al., 1996, 1998;
Serrador et al., 1997; Tsukita et al., 1997; Yonemura et al.,
1998). Association of ERM proteins with the clustered re-
ceptors is receptor specific as we did not observe any colo-
calization of ERM proteins with clusters of HLA class
I antigen or with CD58/LFA-1, a receptor for CD2
(Springer, 1990). The involvement of F-actin in the cross-
linking of monocyte-binding receptors and strengthening
of monocyte-endothelial adhesion is further supported by
the observation that clustering is inhibited by C3 trans-
ferase and cytochalasin D. VCAM-1 did not localize at the
margins of adherent monocytes, although its clustering by
cross-linking antibodies was also dependent on Rho activ-
ity. Therefore, it is likely that monocyte adhesion and
spreading on endothelial cells depends initially on Rho-
regulated clustering of E-selectin and ICAM-1, and that
VCAM-1 plays a role at later stages of monocyte migra-
tion.
Recent evidence suggests that clustering of leukocyte-
binding receptors plays a signaling as well as a mechanical
role in endothelial cells. For example, adhesion of mono-
cytes has been reported to induce a transient increase in
the cytosolic free calcium concentration and also stress fi-
ber assembly in HUVECs, and these responses are mim-
icked by incubation with antibodies against E-selectin,
VCAM-1, or platelet/endothelial cell adhesion molecule
(PECAM-1) (Lorenzon et al., 1998). In addition, cross-
linking of ICAM-1 on brain endothelial cells was reported
to activate Rho and to induce Rho-dependent tyrosine
phosphorylation of focal adhesion kinase, paxillin, and
p130cas (Etienne et al., 1998). Our observation that stress
fiber formation is stimulated in HUVECs after monocyte
adhesion or antibody-induced clustering of E-selectin,
ICAM-1, and VCAM-1 suggests that these events also ac-
tivate Rho. Although we have reported previously that
TNF-a itself induces stress fiber formation in quiescent
HUVECs (Wójciak-Stothard et al., 1998), this is a tran-
sient response and by 4 h after TNF-a addition, when
monocytes or cross-linking antibodies were added, the
background level of stress fibers was low. As the cross-
linking of HLA class I antigen and CD58/LFA-3 did not
result in increased stress fiber formation, this response ap-
pears to be limited to receptors involved in leukocyte in-
teraction.
The mechanisms whereby monocyte-binding receptors
transduce signals in endothelial cells have not been estab-
lished, but interestingly E-selectin can interact via its cyto-
plasmic domain with paxillin and focal adhesion kinase
(Yoshida et al., 1996), which are known to be involved in
integrin-mediated signaling and are activated via a Rho-
regulated pathway (Hemler, 1998). E-Selectin itself is a
target for protein phosphorylation: its cytoplasmic domain
contains several potential phosphorylation sites, at least
one of which becomes phosphorylated in cytokine-acti-
vated HUVECs and may therefore act to recruit signaling
proteins (Smeets et al., 1993).
The cross-linking of E-selectin, ICAM-1, and VCAM-1
induces stress fiber formation, but MLCK inhibitors which
are known to prevent the formation of stress fibers (Chr-
zanowska-Wodnicka and Burridge, 1996; Wójciak-Stoth-
ard et al., 1998) do not inhibit receptor clustering. This
suggests that occupancy of these receptors leads to Rho
activation, which then activates at least two separate sig-
naling pathways, one leading to stress fiber assembly and
another to receptor clustering. As stress fiber formation is
not required for receptor clustering, receptor clustering
represents a new response mediated by Rho signaling. In-
terestingly, introduction of activated V14RhoA into en-
dothelial cells only slightly increased monocyte adhesion,
suggesting that endogenous Rho is strongly activated dur-
ing monocyte binding and that this is sufficient to induce
near-maximal monocyte adhesion. Some of the down-
stream signaling partners involved in Rho-induced stress
fiber formation have been identified (Sahai et al., 1998; re-
viewed in van Aelst and D’Souza-Schory, 1997), and it will
be interesting to determine which of these are involved in
receptor clustering on endothelial cells. In some circum-
stances, Rho can be activated indirectly via Cdc42 and Rac
(Nobes and Hall, 1995; Wójciak-Stothard et al., 1998), but
as the binding of monocytes to endothelial cells was not in-
hibited by dominant negative inhibitors of Cdc42 and Rac,
clustering of receptors is likely to be an effect of direct ac-
tivation of Rho by receptor engagement.
The effect of inhibiting Rho on monocyte binding and
receptor clustering closely resembled that caused by cy-
tochalasin D, suggesting that Rho regulates the linkage of
the actin cytoskeleton to the surface receptors. Incubation
of cells with cytochalasin D leads to gradual loss of actin
filaments, as cytochalasin D acts by binding to barbed ends
of actin filaments and preventing them from further poly-
merization or shortening (Cooper, 1987). Interestingly, C3
transferase and cytochalasin D have also been reported to
inhibit the clustering of Fcg receptors on macrophages in-
duced by opsonized particles, and concomitantly inhibit
Fcg receptor–induced protein tyrosine phosphorylation,
calcium release, and actin cup formation (Hackam et al.,
1997). Together with our results, this suggests that Rho
may be more generally involved in mediating the linkage
of receptors to the actin cytoskeleton, and that this linkage
and resultant receptor clustering is important for cellular
signaling. Precisely how Rho alters receptor clustering isThe Journal of Cell Biology, Volume 145, 1999 1306
not known. It could be required for the formation of links
between receptors and the actin cytoskeleton, once recep-
tors have diffused in the plasma membrane, and thereby
stabilize transient clusters of receptors. Alternatively, it
could be actively involved in regulating the diffusion of re-
ceptors in the plasma membrane.
The mechanism by which Rho regulates links between
receptors and the actin cytoskeleton could well involve
ERM proteins, which interact with both F-actin and sev-
eral adhesion receptors, including ICAM-1 (Heiska et al.,
1996, 1998; Serrador et al., 1997; Tsukita et al., 1997;
Yonemura et al., 1998), and which we have found colocal-
ize with clusters of ICAM-1, VCAM-1, and E-selectin.
ERM proteins also interact with RhoGDI, which is nor-
mally found in the cytoplasm in complex with Rho pro-
teins, and may thereby facilitate Rho targeting to cell ad-
hesion receptors and subsequent activation (Takai et al.,
1995; Hirao et al., 1996; Takahashi et al., 1997).
In conclusion, our data indicate that Rho regulates the
clustering of the monocyte-binding receptors E-selectin,
ICAM-1, and VCAM-1 on the surface of endothelial cells,
probably by enhancing their association with the actin cy-
toskeleton. The assembly of cytoskeletal connections with
the clusters of membrane receptors could then provide
“footholds” for attached monocytes and create the tension
required for their spreading and migration, thereby mim-
icking the more static nature of extracellular matrix. A
similar requirement for association with the actin cytoskel-
eton has been reported for integrins in focal adhesion
complexes and for L-selectin– and LFA-1–mediated adhe-
sion in leukocytes (Pavalko et al., 1995; Chrzanowska-
Wodnicka and Burridge, 1996; Lub et al., 1997). Clustering
of monocyte-binding receptors is not dependent on stress
fibers, in contrast to their involvement in focal adhesion
assembly (Burridge and Chrzanowska-Wodnicka, 1996).
The formation of stress fibers that accompanies cross-link-
ing of membrane receptors may instead serve to provide a
more rigid cell structure to facilitate monocyte migration.
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